Maxillectomy

Maxillectomy is a surgical procedure involving the resection of the maxilla (upper jaw) and is typically performed to remove tumors, treat severe infections, or address other pathological conditions affecting the maxillary region. The procedure requires careful planning and execution to ensure adequate access, removal of the affected tissue, and preservation of surrounding structures for optimal functional and aesthetic outcomes.

Surgical Access and Incision

1. Weber-Fergusson Incision:

   • The classic approach to access the maxilla is through the Weber-Fergusson incision. This incision provides good visibility and access to the maxillary region.
   • Temporary Tarsorrhaphy: The eyelids are temporarily closed using tarsorrhaphy sutures to protect the eye during the procedure.

2. Tattooing for Aesthetic Alignment:

   • To achieve better cosmetic results, it is recommended to tattoo the vermilion border and other key points on both sides of the incision with methylene blue. These points serve as guides for alignment during closure.

3. Incision Design:

   • The incision typically splits the midline of the upper lip but can be modified for better cosmetic outcomes by incising along the philtral ridges and offsetting the incision at the vermilion border.
   • The incision is turned 2 mm from the medial canthus of the eye. Intraorally, the incision continues through the gingival margin and connects with a horizontal incision at the depth of the labiobuccal vestibule, extending back to the maxillary tuberosity.

4. Continuation of the Incision:

   • From the maxillary tuberosity, the incision turns medially across the posterior edge of the hard palate and then turns 90 degrees anteriorly, several millimeters to the proximal side of the midline, crossing the gingival margin again if possible.

5. Incision to Bone:

   • The incision is carried down to the bone, except beneath the lower eyelid, where the orbicularis oculi muscle is preserved. The cheek flap is then reflected back to the tuberosity.

Surgical Procedure

1. Extraction and Elevation:

   • The central incisor on the involved side is extracted, and the gingival and palatal mucosa are elevated back to the midline.

2. Deepening the Incision:

   • The incision extending around the nose is deepened into the nasal cavity. The palatal bone is divided near the midline using a saw blade or bur.

3. Separation of Bone:

   • The basal bone is separated from the frontal process of the maxilla using an osteotome. The orbicularis oculi muscle is retracted superiorly, and the bone cut is extended across the maxilla, just below the infraorbital rim, into the zygoma.

4. Maxillary Sinus:

   • If the posterior wall of the maxillary sinus has not been invaded by the tumor, it is separated from the pterygoid plates using a pterygoid chisel.

5. Specimen Removal:

   • The entire specimen is removed by severing the remaining attachments with large curved scissors placed behind the maxilla.

Postoperative Considerations

• Wound Care: Proper care of the surgical site is essential to prevent infection and promote healing.
• Rehabilitation: Patients may require rehabilitation to address functional issues related to speech, swallowing, and facial aesthetics.
• Follow-Up: Regular follow-up appointments are necessary to monitor healing and assess for any complications or recurrence of disease.

Coagulation Tests: PT and PTT

Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) are laboratory tests used to evaluate the coagulation pathways involved in blood clotting. Understanding these tests is crucial for diagnosing bleeding disorders and managing patients with specific factor deficiencies.

Prothrombin Time (PT)

• Purpose: PT is primarily used to assess the extrinsic pathway of coagulation.
• Factors Tested: It evaluates the function of factors I (fibrinogen), II (prothrombin), V, VII, and X.
• Clinical Use: PT is commonly used to monitor patients on anticoagulant therapy (e.g., warfarin) and to assess bleeding risk before surgical procedures.

Partial Thromboplastin Time (PTT)

• Purpose: PTT is used to assess the intrinsic pathway of coagulation.
• Factors Tested: It evaluates the function of factors I (fibrinogen), II (prothrombin), V, VIII, IX, X, XI, and XII.
• Clinical Use: PTT is often used to monitor patients on heparin therapy and to evaluate bleeding disorders.

Specific Factor Deficiencies

In certain bleeding disorders, specific factor deficiencies can lead to increased bleeding risk. Preoperative management may involve the administration of the respective clotting factors or antifibrinolytic agents to minimize bleeding during surgical procedures.

1. Hemophilia A:

   • Deficiency: Factor VIII deficiency.
   • Management: Administration of factor VIII concentrate before surgery.

2. Hemophilia B:

   • Deficiency: Factor IX deficiency.
   • Management: Administration of factor IX concentrate before surgery.

3. Hemophilia C:

   • Deficiency: Factor XI deficiency.
   • Management: Administration of factor XI concentrate or fresh frozen plasma (FFP) may be considered.

4. Von Willebrand’s Disease:

   • Deficiency: Deficiency or dysfunction of von Willebrand factor (vWF), which is important for platelet adhesion.
   • Management: Desmopressin (DDAVP) may be administered to increase vWF levels, or factor replacement therapy may be used.

5. Antifibrinolytic Agent:

   • Aminocaproic Acid: This antifibrinolytic agent can be used to help stabilize clots and reduce bleeding during surgical procedures, particularly in patients with bleeding disorders.

Intraligamentary Injection and Supraperiosteal Technique

Intraligamentary Injection

• The intraligamentary injection technique is a simple and effective method for achieving localized anesthesia in dental procedures. It requires only a small volume of anesthetic solution and produces rapid onset of anesthesia.

• Technique:

  1. Needle Placement:
     • The needle is inserted into the gingival sulcus, typically on the mesial surface of the tooth.
     • The needle is then advanced along the root surface until resistance is encountered, indicating that the needle is positioned within the periodontal ligament.
  2. Anesthetic Delivery:
     • Approximately 0.2 ml of anesthetic solution is deposited into the periodontal ligament space.
     • For multirooted teeth, injections should be made both mesially and distally to ensure adequate anesthesia of all roots.

• Considerations:

  • Significant pressure is required to express the anesthetic solution into the periodontal ligament, which can be a factor to consider during administration.
  • This technique is particularly useful for localized procedures where rapid anesthesia is desired.

Supraperiosteal Technique (Local Infiltration)

• The supraperiosteal injection technique is commonly used for achieving anesthesia in the maxillary arch, particularly for single-rooted teeth.

• Technique:

  1. Anesthetic Injection:

     • For the first primary molar, the bone overlying the tooth is thin, allowing for effective anesthesia by injecting the anesthetic solution opposite the apices of the roots.

  2. Challenges with Multirooted Teeth:

     • The thick zygomatic process can complicate the anesthetic delivery for the buccal roots of the second primary molar and first permanent molars.
     • Due to the increased thickness of bone in this area, the supraperiosteal injection at the apices of the roots of the second primary molar may be less effective.

  3. Supplemental Injection:

     • To enhance anesthesia, a supplemental injection should be administered superior to the maxillary tuberosity area to block the posterior superior alveolar nerve.
     • This additional injection compensates for the bone thickness and the presence of the posterior middle superior alveolar nerve plexus, which can affect the efficacy of the initial injection.

Necrotizing Sialometaplasia

Necrotizing sialometaplasia is an inflammatory lesion that primarily affects the salivary glands, particularly the minor salivary glands. It is characterized by necrosis of the glandular tissue and subsequent metaplastic changes. The exact etiology of this condition remains unknown, but several factors have been suggested to contribute to its development.

Key Features

1. Etiology:

   • The precise cause of necrotizing sialometaplasia is not fully understood. However, common suggested causes include:
     • Trauma: Physical injury to the salivary glands leading to ischemia (reduced blood flow).
     • Acinar Necrosis: Death of the acinar cells (the cells responsible for saliva production) in the salivary glands.
     • Squamous Metaplasia: Transformation of glandular epithelium into squamous epithelium, which can occur in response to injury or inflammation.

2. Demographics:

   • The condition is more commonly observed in men, particularly in their 5th to 6th decades of life (ages 50-70).

3. Common Sites:

   • Necrotizing sialometaplasia typically affects the minor salivary glands, with common locations including:
     • The palate
     • The retromolar area
     • The lip

4. Clinical Presentation:

   • The lesion usually presents as a large ulcer or an ulcerated nodule that is well-demarcated from the surrounding normal tissue.
   • The edges of the lesion often show signs of an inflammatory reaction, which may include erythema and swelling.

5. Management:

   • Conservative Treatment: The management of necrotizing sialometaplasia is generally conservative, as the lesion is self-limiting and typically heals on its own.
   • Debridement: Gentle debridement of the necrotic tissue may be performed using hydrogen peroxide or saline to promote healing.
   • Healing Time: The lesion usually heals within 6 to 8 weeks without the need for surgical intervention.

Induction Agents in Anesthesia

Propofol is a widely used intravenous anesthetic agent known for its rapid onset and quick recovery profile, making it particularly suitable for outpatient surgeries. It is favored for its ability to provide a clear-headed recovery with a low incidence of postoperative nausea and vomiting. Below is a summary of preferred induction agents for various clinical situations, including the use of propofol and alternatives based on specific patient needs.

Propofol

• Use: Propofol is the agent of choice for most outpatient surgeries due to its rapid onset and quick recovery time.
• Advantages:
  • Provides a smooth induction and emergence from anesthesia.
  • Low incidence of nausea and vomiting, which is beneficial for outpatient settings.
  • Allows for quick discharge of patients after surgery.

Preferred Induction Agents in Specific Conditions

1. Neonates:

   • Agent: Sevoflurane (Inhalation)
   • Rationale: Sevoflurane is preferred for induction in neonates due to its rapid onset and minimal airway irritation. It is well-tolerated and allows for smooth induction in this vulnerable population.

2. Neurosurgery:

   • Agents: Isoflurane with Thiopentone/Propofol/Etomidate
   • Additional Consideration: Hyperventilation is often employed to maintain arterial carbon dioxide tension (PaCO2) between 25-30 mm Hg. This helps to reduce intracranial pressure and improve surgical conditions.
   • Rationale: Isoflurane is commonly used for its neuroprotective properties, while thiopentone, propofol, or etomidate can be used for induction based on the specific needs of the patient.

3. Coronary Artery Disease & Hypertension:

   • Agents: Barbiturates, Benzodiazepines, Propofol, Etomidate
   • Rationale: All these agents are considered equally safe for patients with coronary artery disease and hypertension. The choice may depend on the specific clinical scenario, patient comorbidities, and the desired depth of anesthesia.

4. Day Care Surgery:

   • Agent: Propofol
   • Rationale: Propofol is preferred for day care surgeries due to its rapid recovery profile, allowing patients to be discharged quickly after the procedure. Its low incidence of postoperative nausea and vomiting further supports its use in outpatient settings.

1. Radical Neck Dissection

• Complete removal of all ipsilateral cervical lymph node groups (levels I-V) and three key non-lymphatic structures:
  • Internal jugular vein
  • Sternocleidomastoid muscle
  • Spinal accessory nerve
• Indication: Typically performed for extensive lymphatic involvement.

2. Modified Radical Neck Dissection

• Similar to radical neck dissection in terms of lymph node removal (levels I-V) but with preservation of one or more of the following structures:
  • Type I: Preserves the spinal accessory nerve.
  • Type II: Preserves the spinal accessory nerve and the sternocleidomastoid muscle.
  • Type III: Preserves the spinal accessory nerve, sternocleidomastoid muscle, and internal jugular vein.
• Indication: Used when there is a need to reduce morbidity while still addressing lymphatic involvement.

3. Selective Neck Dissection

• Preservation of one or more lymph node groups that are typically removed in a radical neck dissection.
• Classification:
  • Originally had named dissections (e.g., supraomohyoid neck dissection for levels I-III).
  • The 2001 modification proposed naming dissections based on the cancer type and the specific node groups removed. For example, a selective neck dissection for oral cavity cancer might be referred to as a selective neck dissection (levels I-III).
• Indication: Used when there is a lower risk of lymphatic spread or when targeting specific areas.

4. Extended Neck Dissection

•  Involves the removal of additional lymph node groups or non-lymphatic structures beyond those included in a radical neck dissection. This may include:
  • Mediastinal nodes
  • Non-lymphatic structures such as the carotid artery or hypoglossal nerve.
• Indication: Typically performed in cases of extensive disease or when there is a need to address additional areas of concern.